Stock overview
Ascendis Pharma A/S - US
Explore the company, reported ownership, price history, and available source evidence.
Ascendis Pharma ordinary shares, traded on Nasdaq as ASND since April 20, 2026 following the one-for-one ADS exchange. Ascendis develops and commercializes medicines using its TransCon technology.
- Last close
- $270.33
- · ASND
- Tracked holders
- 3 funds
- Latest available 13F per fund
ASND · USD
Price
Close · Nov 18, 2026
- Range low
- $205.81
- Range high
- $277.18
- Observations
- 149
- Session date
- Nov 18, 2026
Apr 20, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
No holders match this filter.
Try another movement slice or return to the full holder table.
Show all holdersSEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market